Marques-Costa JC, Cuzzi T, Carneiro S, Parish LC, Ramos-e-Silva M.
Skinmed. 2012 May-Jun;10(3):160-5; quiz 165.
PMID:22779098
Quality assessment of a large primary GP skin cancer service in Auckland, New Zealand.
Wen D, Gale K, Martin R.
N Z Med J. 2020 Feb 7;133(1509):17-27.
PMID:32027635
In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Oba T, Makino K, Kajihara R, Yokoi T, Araki R, Abe M, Minderman H, Chang AE, Odunsi K, Ito F.